Cardiologists today prescribe medications with complex mechanisms of action, pharmacokinetics, indications, contraindications and drug-frug interactions; many of which were not available when today's practitioners were in training. This book was written to meet the growing demand for complete, detailed and accurate cardiac pharmacology information.

This in-depth examination of the specific types of pharmacological agents used in the cardiac catheterization lab - as well as those routinely prescribed for cardiac patients - evaluates drugs with respect to their:

• Cellular and physiological actions
• Prescribed usage
• Dosages
• Adverse reactions
• Cautions
• Common routes of administration

Opening chapters discuss anticoagulation therapies and antiplatelet therapies. later chapters cover percutaneous coronary intervention and its possible complications, post-procedure pharmacotherapy, and anticoagulation anomalies.

Drawing on the expertise of contributors from around the world, Pharmacology in the Catheterization Laboratory is the perfect blend of evidence and experience.

Ron Waksman, MD, FACC. Associate Director, Division of Cardiology, Washington Hospital Center (WHC) and Director of Experimental Angioplasty & Emerging Technologies, Cardiovascular Research Institute(CRI) at WHC, Washington, DC USA.

Andrew E. Ajani, Australia.